Skip to main content
Veterinary Medicines

AQUAVAC VIBRIO ORAL

Authorised
  • Vibrio anguillarum, serotype O1, strain 78-SKID, Inactivated
  • Vibrio ordalii, strain MSC275, Inactivated

Product identification

Medicine name:
AQUAVAC VIBRIO ORAL
AQUAVAC VIBRIO
Active substance:
  • Vibrio anguillarum, serotype O1, strain 78-SKID, Inactivated
  • Vibrio ordalii, strain MSC275, Inactivated
Target species:
  • Trout
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Vibrio anguillarum, serotype O1, strain 78-SKID, Inactivated
    60.00
    Relative Percentage Survival
    /
    1.00
    Dose
  • Vibrio ordalii, strain MSC275, Inactivated
    60.00
    Relative Percentage Survival
    /
    1.00
    Dose
Pharmaceutical form:
  • Oral emulsion
Withdrawal period by route of administration:
  • Oral use
    • Trout
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI10BB01
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • 1000 ml bottle (10 000 doses as revaccination scheme, 5000 doses as primary vaccination)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Merck Sharp & Dohme Animal Health S.L.
  • MSD Animal Health UK Limited
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 16217/13-03-2008/K-0163701
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0165/001
Concerned member states:
  • Cyprus
  • Greece
  • Italy
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."